Approvals/NMPA/RHaemorrhagic Fever with Renal Syndrome Bivalent Purified Vaccine (Vero cell)

Approved

生物制品

RHaemorrhagic Fever with Renal Syndrome Bivalent Purified Vaccine (Vero cell)

兰州生物制品研究所有限责任公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaeCzV2To
Approval Number: 国药准字S20050109
Generic Name: 双价肾综合征出血热纯化疫苗(Vero细胞)
Generic Name En: RHaemorrhagic Fever with Renal Syndrome Bivalent Purified Vaccine (Vero cell)
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 每瓶1.0ml。每1次人用剂量为1.0ml。
Reg Date: 2020-06-22
Company Name: 兰州生物制品研究所有限责任公司
Production Company Name: 兰州生物制品研究所有限责任公司
Production Company Address: 兰州市城关区盐场路888号
Company Detail Path: /organization/lan-zhou-sheng-wu-zhi-pin-yan-jiu-suo-you-xian-ze-ren-gong-si
Production Company Detail Path: /organization/lan-zhou-sheng-wu-zhi-pin-yan-jiu-suo-you-xian-ze-ren-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 22, 2020

Approval ID

7LeaeCzV2To

Type

生物制品